Macquarie Group LTD Acadia Pharmaceuticals Inc Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

A detailed history of Macquarie Group LTD transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Macquarie Group LTD holds 92,648 shares of ACAD stock, worth $1.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

92,648

Previous 92,648 -0.0%

Holding current value

$1.58 Million

Previous $1.51 Million 5.32%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$14.62 - $18.42 $5.48 Million - $6.9 Million	-374,807 Reduced 80.18%	92,648 $1.51 Million
Q1 2024 May 14, 2024	BUY	$17.79 - $30.86 $6.76 Million - $11.7 Million	379,807 Added 433.33%	467,455 $8.64 Million
Q4 2023 Feb 14, 2024	SELL	$20.78 - $31.77 $1.5 Million - $2.3 Million	-72,352 Reduced 45.22%	87,648 $2.74 Million
Q4 2022 Feb 21, 2023	SELL	$14.2 - $18.63 $42,088 - $55,219	-2,964 Reduced 1.82%	160,000 $2.55 Million
Q3 2022 Nov 14, 2022	SELL	$14.11 - $18.27 $30,421 - $39,390	-2,156 Reduced 1.31%	162,964 $2.7 Million
Q1 2022 May 16, 2022	SELL	$20.94 - $27.5 $79,697 - $104,665	-3,806 Reduced 2.25%	165,120 $4 Million
Q4 2021 Feb 11, 2022	SELL	$16.79 - $27.09 $4,650 - $7,503	-277 Reduced 0.16%	168,926 $3.94 Million
Q3 2021 Nov 12, 2021	BUY	$15.78 - $24.77 $83,271 - $130,711	5,277 Added 3.22%	169,203 $2.81 Million
Q1 2021 May 14, 2021	SELL	$25.02 - $54.99 $1.42 Million - $3.12 Million	-56,727 Reduced 25.71%	163,926 $4.23 Million
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $72,025 - $99,666	-1,755 Reduced 0.79%	220,653 $11.8 Million
Q3 2020 Nov 13, 2020	SELL	$36.42 - $57.0 $2.13 Million - $3.34 Million	-58,605 Reduced 20.85%	222,408 $9.18 Million
Q2 2020 Aug 11, 2020	SELL	$39.26 - $52.73 $229,199 - $307,837	-5,838 Reduced 2.04%	281,013 $13.6 Million
Q1 2020 May 15, 2020	BUY	$31.65 - $46.87 $1.18 Million - $1.75 Million	37,407 Added 15.0%	286,851 $12.1 Million
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $594,966 - $844,553	16,431 Added 7.05%	249,444 $10.7 Million
Q3 2019 Nov 14, 2019	SELL	$22.22 - $44.01 $296,925 - $588,105	-13,363 Reduced 5.42%	233,013 $8.39 Million
Q2 2019 Aug 14, 2019	BUY	$23.32 - $28.12 $45,240 - $54,552	1,940 Added 0.79%	246,376 $6.59 Million
Q1 2019 May 15, 2019	SELL	$16.17 - $27.38 $175,428 - $297,045	-10,849 Reduced 4.25%	244,436 $6.56 Million
Q4 2018 Feb 15, 2019	BUY	$14.32 - $22.92 $2.04 Million - $3.26 Million	142,321 Added 125.99%	255,285 $4.13 Million
Q3 2018 Nov 15, 2018	BUY	$13.03 - $21.81 $1.47 Million - $2.46 Million	112,964 New	112,964 $2.35 Million
Q1 2018 May 11, 2018	SELL	$22.47 - $32.33 $161,784 - $232,776	-7,200 Closed	0 $0
Q4 2017 Feb 15, 2018	SELL	$26.84 - $39.14 $1.92 Million - $2.8 Million	-71,610 Reduced 90.86%	7,200 $217,000
Q3 2017 Nov 08, 2017	BUY	$29.49 - $38.37 $2.32 Million - $3.02 Million	78,810	78,810 $2.97 Million

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Acadia Pharmaceuticals Inc Transaction History